FMA
NPTN

FNY Managed Accounts’s NEOPHOTONICS CORP NPTN Stock Holding History

FNY Managed Accounts’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,000
Closed -$9K – 702
2017
Q1 		$9K Buy
+1,000
New +$10.4K 0.03% 527

Other funds holding NPTN

OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
QAM
Quentec Asset Management New York $634M AUM 22.87% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

FNY Managed Accounts's NPTN Position: Q2 2017 in Review

FNY Managed Accounts sold out of NEOPHOTONICS CORP (NPTN) in Q2 2017, closing a stake of 1,000 shares — an estimated $9K sold.

FNY Managed Accounts first reported a position in NPTN in Q1 2017 and held it in 1 quarter. The position peaked at $9K in Q1 2017. 101 funds tracked by Wall St. Rank hold NPTN as of Q2 2017.

  • FNY Managed Accounts reported no remaining NEOPHOTONICS CORP position as of Q2 2017 after selling out during the quarter.
  • FNY Managed Accounts sold 1,000 NEOPHOTONICS CORP shares in Q2 2017, an estimated $9K.
  • FNY Managed Accounts first reported a position in NEOPHOTONICS CORP in Q1 2017 and held it in 1 quarter.
  • FNY Managed Accounts's NEOPHOTONICS CORP position peaked at $9K in Q1 2017.
  • 101 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2017.

Based on FNY Managed Accounts's 13F filing for Q2 2017, filed 10 Aug 2017.